Metraipolis › archive › dc_af1564a2f7bc
A pragmatic trial with an optimized dose of rifampicin and moxifloxacin for the treatment of drug-susceptible pulmonary tuberculosis: A study protocol for… — Europe PMC PPR:PPR1102732
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR1102732
- DOI
- 10.21203/rs.3.rs-7238156/v1
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T07:08:23.324Z
- SHA-256 of the archived text
6ce916b5f0deef1d77f82fcfed9ae46dec9f02c9c356c3978c500d336a913eae- Stable URL of this page
https://metraipolis.com/documento/dc_af1564a2f7bc
How to cite
A pragmatic trial with an optimized dose of rifampicin and moxifloxacin for the treatment of drug-susceptible pulmonary tuberculosis: A study protocol for… — Europe PMC PPR:PPR1102732 — Europe PMC, https://europepmc.org/article/PPR/PPR1102732 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_af1564a2f7bc (Metraipolis archive dc_af1564a2f7bc, sha256 6ce916b5f0deef1d77f82fcfed9ae46dec9f02c9c356c3978c500d336a913eae)
BibTeX
@misc{dcaf1564a2f7bc,
title = {A pragmatic trial with an optimized dose of rifampicin and moxifloxacin for the treatment of drug-susceptible pulmonary tuberculosis: A study protocol for… — Europe PMC PPR:PPR1102732},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR1102732},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_af1564a2f7bc; sha256 6ce916b5f0deef1d77f82fcfed9ae46dec9f02c9c356c3978c500d336a913eae},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1102732. Agents can read the archived copy with the MCP tool read_document.